Joel Mccleary - Net Worth and Insider Trading

Joel Mccleary Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joel Mccleary owns 1 companies in total, including Altimmune Inc (ALT) .

Click here to see the complete history of Joel Mccleary’s form 4 insider trades.

Insider Ownership Summary of Joel Mccleary

Ticker	Comapny	Transaction Date	Type of Owner
ALT	Altimmune Inc	2008-04-28	director

Joel Mccleary Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Joel Mccleary Ownership Network

Ownership Network List of Joel Mccleary

No Data

Ownership Network Relation of Joel Mccleary

Joel Mccleary Owned Company Details

What does Altimmune Inc do?

Who are the key executives at Altimmune Inc?

Joel Mccleary is the director of Altimmune Inc. Other key executives at Altimmune Inc include Chief Financial Officer Richard I Eisenstadt , Chief Medical Officer Matthew Scott Harris , and Chief Business Officer Raymond M Jordt .

Altimmune Inc (ALT) Insider Trades Summary

Over the past 18 months, Joel Mccleary made no insider transaction in Altimmune Inc (ALT). Other recent insider transactions involving Altimmune Inc (ALT) include a net sale of 6,711 shares made by David Drutz , a net purchase of 10,000 shares made by Richard I Eisenstadt , and a net purchase of 10,000 shares made by Matthew Scott Harris .

In summary, during the past 3 months, insiders sold 16,011 shares of Altimmune Inc (ALT) in total and bought 0 shares, with a net sale of 16,011 shares. During the past 18 months, 16,011 shares of Altimmune Inc (ALT) were sold and 29,300 shares were bought by its insiders, resulting in a net purchase of 13,289 shares.

Altimmune Inc (ALT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Altimmune Inc Insider Transactions

No Available Data

Joel Mccleary Mailing Address

Above is the net worth, insider trading, and ownership report for Joel Mccleary. You might contact Joel Mccleary via mailing address: C/o Pharmathene, Inc, One Park Place, Suite 450, Annapolis Md 21401.

Discussions on Joel Mccleary

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.